chapter 1 Oral Modified-Release Delivery Systems / chapter 2 TIMERx Oral Controlled-Release Drug Delivery System / chapter 3 MASRx and COSRx Sustained-Release Technology / chapter 4 Procise: Drug Delivery Systems Based on Geometric Configuration / chapter 5 RingCap Technology / chapter 6 Smartrix System: Design Characteristics and Release Properties of a Novel Erosion-Controlled Oral Delivery System / chapter 7 TheriForm Technology / chapter 8 Accudep Technology for Oral Modified Drug Release / chapter 9 Osmotically Controlled Tablets / chapter 10 Three-Phase Pharmaceutical Form—THREEFORM—with Controlled Release of Amorphous Active Ingredient for Once- Daily Administration / chapter 11 Two Concepts, One Technology: Controlled-Release and Solid Dispersions with Meltrex / chapter 12 DissoCubes—A Novel Formulation for Poorly Soluble and Poorly Bioavailable Drugs / chapter 13 IDD Technology: Oral Delivery of Water-Insoluble Drugs Using Phospholipid Stabilized Microparticulate IDD Formulations / chapter 14 Liquid-Filled and -Sealed Hard Gelatin Capsule Technologies / chapter 15 The Zydis Oral Fast-Dissolving Dosage Form / chapter 16 Orasolv and Durasolv: Efficient Technologies for the Production of Orally Disintegrating Tablets / chapter 17 Colonic Drug Delivery / chapter 18 Enteric Coating for Colonic Delivery / chapter 19 Biopolymers and Colonic Delivery / chapter 20 Time-Dependent Systems for Colonic Delivery / chapter 21 New Approaches for Optimizing Oral Drug Delivery: Zero- Order Sustained Release to Pulsatile Immediate Release Using the Port System / chapter 22 Pulsincap and Hydrophilic Sandwich (HS) Capsules: Innovative Time-Delayed Oral Drug Delivery Technologies / chapter 23 Development of the Egalet Technology / chapter 24 The Enterion Capsule / chapter 25 Ophthalmic Drug Delivery / chapter 26 Ion Exchange Resin Technology for Ophthalmic Applications / chapter 27 New Ophthalmic Delivery System (NODS) / chapter 28 Bioadhesive Ophthalmic Drug Inserts (BODI) / chapter 29 Oral Mucosal Drug Delivery / chapter 30 Slowly Disintegrating Buccal Mucoadhesive Plain-Tablet (S-DBMP-T) and Buccal Covered-Tablet System (BCTS) / chapter 31 The Oral PowderJect Device for Mucosal Drug Delivery / chapter 32 The PerioChip / chapter 33 Polysaccharide-Based Mucoadhesive Buccal Tablets / chapter 34 Medicated Chewing Gum / chapter 35 Immediate-Immediate Release (I2R) Lingual or Buccal Spray Formulations for Transmucosal Delivery of Drug Substances / chapter 36 Liquid Crystalline Phases of Glyceryl Mono-oleate as Oral Mucosal Drug Delivery Systems / chapter 37 Microparticles as Delivery Systems for Local Delivery to the Oral Cavity / chapter 38 OraVescent: A Novel Technology for the Transmucosal Delivery of Drugs / chapter 39 Dermal and Transdermal Delivery / chapter 40 D-TRANS Technology / chapter 41 Chapter E-TRANS Technology / chapter 42 Microfabricated Microneedles for Transdermal Drug Delivery / chapter 43 Metered-Dose Transdermal Spray (MDTS) / chapter 44 Transfersomes: Innovative Transdermal Drug Carriers / chapter 45 Advances in Wound Healing / chapter 46 Ultrasound-Mediated Transdermal Drug Delivery / chapter 47 SLN and Lipopearls for Topical Delivery of Active Compounds and Controlled Release / chapter 48 Macroflux Technology for Transdermal Delivery of Therapeutic Proteins and Vaccines / chapter 49 Needle-Free Drug Delivery / chapter 50 Dermal PowderJect Device / chapter 51 Intraject: Prefilled, Disposable, Needle-Free Injection of Liquid Drugs and Vaccines / chapter 52 Implants and Injectables / chapter 53 Alzamer Depot Bioerodible Polymer Technology / chapter 54 The Atrigel Drug Delivery System / chapter 55 Long-Term Controlled Delivery of Therapeutic Agents via an Implantable Osmotically Driven System: The DUROS Implant / chapter 56 Long-Acting Protein Formulations—ProLease Technology / chapter 57 Sucrose Acetate Isobutyrate (SAIB) for Parenteral Delivery / chapter 58 Stealth Technology / chapter 59 DepoFoam Technology / chapter 60 Medipad Delivery System: Controlled Macromolecule Delivery / chapter 61 Intranasal Drug Delivery / chapter 62 Poly(ethylene oxide)-b-Poly(propylene oxide)-b-Poly(ethylene oxide)-g-Poly(acrylic acid) Copolymers as In Situ Gelling Vehicle for Nasal Delivery / chapter 63 Intravaginal Drug Delivery Technologies / chapter 64 The Intravaginal Ring / chapter 65 SupraVail Vaginal Gel / chapter 66 VagiSite Bioadhesive Technology / chapter 67 Pulmonary Delivery of Drugs by Inhalation / chapter 68 Aerogen Pulmonary Delivery Technology / chapter 69 The AERx Pulmonary Drug Delivery System / chapter 70 Formulation Challenges of Powders for the Delivery of Small Molecular Weight Molecules as Aerosols / chapter 71 Nebulizer Technologies / chapter 72 The Pressurized Metered-Dose Inhaler / chapter 73 Passive Dry Powder Inhalation Technology / chapter 74 Formulation Challenges: Protein Powders for Inhalation / chapter 75 The Development of Large Porous Particles for Inhalation Drug Delivery / chapter 76 Dry Powder Inhalation Systems from Inhale Therapeutic Systems / chapter 77 Spiros Inhaler Technology / chapter 78 The Respimat, a New Soft Mist Inhaler for Delivering Drugs to The Lungs / chapter 79 Regulatory Issues for Pulmonary Delivery Systems / chapter 80 Regulatory Issues Relating to Modified-Release Drug Formulations